Cellcolabs Revenue and Competitors
Estimated Revenue & Valuation
- Cellcolabs's estimated annual revenue is currently $13.9M per year.
- Cellcolabs's estimated revenue per employee is $155,000
Employee Data
- Cellcolabs has 90 Employees.
- Cellcolabs grew their employee count by 43% last year.
Cellcolabs's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Marketing Officer | Reveal Email/Phone |
2 | Chief Medical Affairs, Chief Medical Officer | Reveal Email/Phone |
3 | Head Business Development | Reveal Email/Phone |
4 | QA Manager | Reveal Email/Phone |
5 | Strategy & Business Manager | Reveal Email/Phone |
6 | Project Manager | Reveal Email/Phone |
7 | Marketing Operations & Content Manager | Reveal Email/Phone |
8 | Communications Manager | Reveal Email/Phone |
9 | Office Manager | Reveal Email/Phone |
10 | QA | Reveal Email/Phone |
Cellcolabs Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $140.3M | 905 | 14% | N/A | N/A |
#2 | $18.9M | 122 | -15% | N/A | N/A |
#3 | $23.4M | 151 | 5% | N/A | N/A |
#4 | $27.7M | 179 | -14% | N/A | N/A |
#5 | $8.8M | 57 | -12% | N/A | N/A |
#6 | $5.3M | 34 | -35% | N/A | N/A |
#7 | $26M | 168 | 20% | N/A | N/A |
#8 | $17.5M | 113 | -23% | N/A | N/A |
#9 | $12.7M | 82 | 14% | N/A | N/A |
#10 | $30.7M | 198 | 16% | N/A | N/A |
What Is Cellcolabs?
Cellcolabs is on a mission to revolutionize healthcare through advanced cell therapies. We produce GMP mesenchymal stromal cells to accelerate clinical development and implementation of stem cell therapies. \n\nJoin the stem cell revolution. Together we can improve the future of global health.\n\nFor patients, please visit: https://clinical.cellcolabs.ae/
keywords:N/AN/A
Total Funding
90
Number of Employees
$13.9M
Revenue (est)
43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.6M | 94 | -12% | N/A |
#2 | $21.1M | 96 | 10% | N/A |
#3 | $15.5M | 97 | 64% | N/A |
#4 | $15.5M | 107 | -18% | N/A |
#5 | $17.3M | 108 | 15% | N/A |